Redmile Group’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.5M | Sell |
|
|||||
|
2025
Q1 | $48.1M | Sell |
|
|||||
|
2024
Q4 | $79M | Sell |
|
|||||
|
2024
Q3 | $96.2M | Sell |
|
|||||
|
2024
Q2 | $92.3M | Sell |
|
|||||
|
2024
Q1 | $65.9M | Buy |
|
|||||
|
2023
Q4 | $33.6M | Buy |
|
|||||
|
2023
Q3 | $22.4M | Sell |
|
|||||
|
2023
Q2 | $28.5M | Buy |
|
|||||
|
2023
Q1 | $24.4M | Sell |
|
|||||
|
2022
Q4 | $32.9M | Sell |
|
|||||
|
2022
Q3 | $39.2M | Hold |
|
|||||
|
2022
Q2 | $38.1M | Sell |
|
|||||
|
2022
Q1 | $42.3M | Buy |
|
|||||
|
2021
Q4 | $85.6M | Sell |
|
|||||
|
2021
Q3 | $92.7M | Sell |
|
|||||
|
2021
Q2 | $84.6M | Sell |
|
|||||
|
2021
Q1 | $103M | Buy |
|
|||||
|
2020
Q4 | $93.6M | Buy |
|
|||||
|
2020
Q3 | $90.5M | Buy |
|